BioFrontiers' Will Old is leading the SPARTA team.

CU-Boulder lab awarded $14.6 million DARPA contract

Feb. 3, 2014

The University of Colorado was recently awarded a cooperative agreement worth up to $14.6 million from the Defense Advanced Research Projects Agency (DARPA) to develop a new technological system to rapidly determine how drugs and biological or chemical agents affect human cells. The project, called the Subcellular Pan-Omics for the...

Huntley, Dowell and Driscoll work in the Sequencing Facility (Photo: Casey Cass)

BioFrontiers partners with Avery Brewing

Jan. 31, 2014

BioFrontiers partners with world’s oldest biotech industry: Breweries In the basement of the Jennie Smoly Caruthers Biotechnology Building on CU-Boulder’s East Campus sits a machine that can sequence roughly 6 billion DNA segments in about a week. By comparison, human DNA consists of roughly 3 billion bases, and it took...

JSCBB's Butcher Auditorium was packed for the day-long event.

JSCBB Mini Symposium

Dec. 19, 2013

JSCBB Mini Symposium Encourages Collaboration It looks a lot like the other buildings on the CU-Boulder campus, with its rustic Italian-inspired tile roof and red brick, but the Jennie Smoly Caruthers Biotechnology Building (affectionately known by its inhabitants as JSCBB) is something quite different. It was designed to support those...

Joey Azofeifa is a second-year graduate student in the IQ Biology program. He works in Robin Dowell's lab at the BioFrontiers Institute.

Science is Hard

Nov. 18, 2013

It must be said that I have had a very difficult time writing this blog-post. The reason, after a few too many cups of coffee, came clear to me: Science is Hard (and I worried if that’s what I should tell my readers). Certainly there are intellectual struggles in Science,...

igem

CU Boulder to go to iGEM

Oct. 17, 2013

CU-Boulder Student Team Wows Judges at Premiere Biology Competition When this year’s iGEM team at the University of Colorado Boulder began meeting early this year, they wanted to take what they knew about biology, and use it to build something entirely new. iGEM, or International Genetically Engineered Machine , is...

Nora Connor is a third-year graduate student in the IQ Biology program.

IQ Biology Blog: On the leading edge

Sept. 6, 2013

Studying Quantitative Genomics in Italy By: Nora Connor I returned this past weekend from a conference and workshop called Quantitative Laws of Genome Evolution in Lake Como, Italy. An Italian physicist named Marco Lagomarsino created the conference, which brought together an interdisciplinary group of statistical physicists, biophysicists, chemists and biologists...

The hammerhead ribozyme in the Ireland Botanical National Gardens.

IQ Biology Blog: Understanding RNA

July 16, 2013

The newly constructed structure in the National Botanical Gardens in Ireland, meant to symbolize the flow of information from DNA to RNA and proteins, contains a representation of the DNA double helix, a ribosome, and thehammerhead ribozyme. Sculptures of the DNA helix have been constructed all over the world ;...

A cardiomyocyte imaged by the BioFrontiers Advanced Imaging Facility.

BioFrontiers Scientist Tackles a Childhood Disease of the Heart

Feb. 27, 2013

BioFrontiers scientist tackles a childhood disease of the heart BioFrontiers Chief Scientific Officer Leslie Leinwand, has been studying the motor protein, myosin, for 25 years. This important protein is responsible for making muscles contract, including one vital muscle: your heart. Myosin drives heart muscle contraction, and when this protein is...

Ryan tends to a tranquilized bear during field work in Missouri.

IQ Bio Blog: Interdisciplinarity on Steroids

Feb. 6, 2013

IQ Bio Blog: Interdisciplinarity on Steroids by: Ryan Langendorf At my last mentoring committee meeting, after discussing the tug-of-war that the Environmental Studies and IQ Biology programs have been playing with my schedule, Dr. Brett Melbourne paused and quietly commented that my life is “interdisciplinarity on steroids!” We all laughed,...

Leslie Leinwand, MCDB Professor and BioFrontiers Intitute Chief Scientific Officer

BioFrontiers scientist eyes heart disease treatment

Feb. 5, 2013

CU professor co-founds new company to develop genetic heart disease treatment A new biomedical company involving the University of Colorado Boulder, Stanford University and the Harvard Medical School has been launched with $38 million in financing from Third Rock Ventures LLC headquartered in Boston and San Francisco to develop therapeutic...

Pages